ArticleBMJ (Clinical research ed.)2026
Global, regional, and national levels and trends in older child, adolescent, and youth (5-24 years) all cause mortality from 1990 to 2024: modelling study.
Article in BMJ (Clinical research ed.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
objectiveTo estimate all cause mortality among children, adolescents, and youths aged 5-24 years for 200 countries and areas from 1990 to 2024, to assess mortality levels and trends, and to identify which regions and countries require the greatest investment.
designDatabase construction of empirical data on mortality, mortality estimation, and assessment of levels and trends. DATA AND
methodsMortality databases were constructed from all available nationally representative data including vital registration data, sample vital registration data, household surveys, and population censuses to estimate mortality risk in the age groups in people aged 5 to 24 years.
resultsIn 2024, an estimated 2.1 million (90% uncertainty interval (UI) 2.1 million to 2.4 million) people aged 5-24 years died worldwide, representing 31% of all 7.0 million deaths under 25 years of age. This figure, an increase from 21% (3.3 million of 16.3 million) in 1990, reflects this age group's increasing epidemiological importance as mortality in children under 5 years old declines faster. Globally, mortality risk was lowest at ages 10-14 years (2.7 (90% UI 2.5 to 3.3) deaths per 1000) and increased at ages 15-19 years (4.3 (4.1 to 4.6)) and 20-24 years (6.1 (5.7 to 7.7)). Male mortality was consistently higher than female mortality, with the male to female ratio increasing with age. Progress has been uneven: mortality fell by 64% for people aged 5-9 years from 1990 to 2024, compared with 33% for people aged 20-24 years, with slower declines in male mortality, particularly in older youth (26% reduction in male mortality
conclusionProgress in reducing mortality in people aged 5-24 years has been uneven and has slowed. Urgent, context specific investments-particularly in high mortality regions-are needed to reduce preventable deaths and strengthen mortality monitoring data systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.